Difference between revisions of "Rasburicase (Elitek)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) |
m (Text replacement - "[[Media:" to "[[File:") |
||
Line 1: | Line 1: | ||
==General information== | ==General information== | ||
− | Class/mechanism: Recombinant urate-oxidase. Rasburicase catalyzes the enzymatic oxidation of poorly soluble uric acid into allantoin, an inactive and more soluble metabolite.<ref name="insert">[http://products.sanofi.us/elitek/elitek.pdf Rasburicase (Elitek) package insert]</ref><ref>[[ | + | Class/mechanism: Recombinant urate-oxidase. Rasburicase catalyzes the enzymatic oxidation of poorly soluble uric acid into allantoin, an inactive and more soluble metabolite.<ref name="insert">[http://products.sanofi.us/elitek/elitek.pdf Rasburicase (Elitek) package insert]</ref><ref>[[File:Rasburicase.pdf | Rasburicase (Elitek) package insert (locally hosted backup)]]</ref><ref>[http://www.elitek.us/ Elitek manufacturer's website]</ref> |
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: no information | <br>Extravasation: no information |
Revision as of 00:17, 20 September 2021
General information
Class/mechanism: Recombinant urate-oxidase. Rasburicase catalyzes the enzymatic oxidation of poorly soluble uric acid into allantoin, an inactive and more soluble metabolite.[1][2][3]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Brief patient counseling information can be found in the Rasburicase (Elitek) package insert[1]
History of changes in FDA indication
- 7/12/2002: FDA approved "for initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid."[1]
Also known as
- Brand names: Elitek, Fasturtec, Rasbelon, Rasburnat, Rasby